A multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy

Media formats available:

Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
- Alexander J. Blood, MD
A practical look at cardiorenal protection for CKD in T2D: Applying recent data
A practical look at cardiorenal protection for CKD in T2D: Applying recent data
Kidney Disease
A practical look at cardiorenal protection for CKD in T2D: Applying recent data
- Carolyn Lam, MD, PhD
- Maria Luiza Caramori, MD, PhD
- Ana Maria Cebrián-Cuenca, MD, PhD
- Carolyn Lam, MD
Management of patients with CKD and HF complicated by hyperkalemia
Management of patients with CKD and HF complicated by hyperkalemia
Kidney Disease
Management of patients with CKD and HF complicated by hyperkalemia
- Ellie Kelepouris, MD
- Stephen J. Greene, MD
Inorganic nitrate reduces risk of contrast-induced nephropathy after coronary angiography
Inorganic nitrate reduces risk of contrast-induced nephropathy after coronary angiography
ESC Congress 2023
Inorganic nitrate reduces risk of contrast-induced nephropathy after coronary angiography
- Dan Jones, MD, PhD

PACE-CME